“Tuberculosis is curable, but cure does not always mean that the lungs return to normal”. This distinction is one of the most important things I explain to patients who come to the thoracic surgery clinic months or even years after completing tuberculosis treatment. Their sputum tests may be negative. Their anti-tubercular medicines may have ended long ago. Yet they may still be coughing every day, producing large amounts of sputum, suffering repeated chest infections, becoming breathless with ordinary activity, or suddenly coughing up blood, which brings us to the question “when is surgery needed after TB”
Why does this happen?
Think of pulmonary tuberculosis as a fire inside a house. Antibiotics can extinguish the fire, but they cannot always rebuild the rooms damaged by it. In the lungs, healed tuberculosis may leave behind cavities, fibrosis, distorted bronchi, bronchiectasis, pleural thickening, calcification, fungal infection, or even destruction of an entire lobe or lung. These structural changes are increasingly recognised under the broad concept of post-tuberculosis lung disease, or PTLD.
The important question is not simply, “Did you have TB?” The more useful question is: “What damage has TB left behind, and is that damage now causing a problem that cannot be controlled without surgery?”
Most people who have recovered from tuberculosis do not need an operation. Surgery is reserved for carefully selected situations in which a damaged portion of the lung has become a persistent source of bleeding, infection, fungal disease, pus, or major functional problems. The decision requires careful evaluation because surgery after TB can be technically more demanding than routine lung surgery.
This article explains when surgery is needed after TB, what symptoms should raise concern, what tests are required before surgery, and which operations may be considered.
TB May Be Cured, but the Lung May Remain Damaged
Tuberculosis is one of the most important infectious diseases worldwide, and the scale of the problem remains enormous. According to the latest global estimates, approximately 10.7 million people developed TB in 2024. As treatment and survival improve, another challenge becomes increasingly visible: what happens to the lungs after microbiological cure?
A patient may complete treatment successfully but be left with permanent structural changes. These can include scarring, lung volume loss, thickened pleura, cavities, airway distortion, bronchiectasis, and areas of severely damaged or non-functioning lung. Some people remain almost completely asymptomatic. Others develop chronic respiratory problems that significantly affect quality of life.
The pattern varies greatly from patient to patient. One person may have a small scar visible only on a CT scan. Another may have severe upper-lobe bronchiectasis causing daily production of infected sputum. A third may develop an aspergilloma inside an old TB cavity and present with recurrent haemoptysis. At the extreme end of the spectrum, an entire lung may become shrunken, fibrotic, bronchiectatic, and chronically infected—a condition commonly called a post-TB destroyed lung.
This is why treatment after TB cannot be based on the chest X-ray alone. A frightening-looking scan does not automatically mean that surgery is necessary, while a relatively localised abnormality may require intervention if it repeatedly causes dangerous bleeding.
Understanding Post-Tuberculosis Lung Disease
Post-tuberculosis lung disease is a broad term describing chronic respiratory abnormalities attributable, at least partly, to previous pulmonary TB. Modern respiratory literature increasingly emphasises that the end of anti-tubercular treatment should not necessarily be the end of clinical assessment, especially when symptoms continue.
PTLD can produce different combinations of obstructive lung disease, restrictive impairment, bronchiectasis, cavitation, fibrosis, pleural disease, pulmonary vascular problems, and secondary infections. This diversity explains why there is no single treatment called “post-TB surgery.” The surgeon does not operate on the history of tuberculosis itself; the operation is directed at a specific structural complication.
For example, a patient with diffuse bilateral fibrosis and breathlessness will usually not benefit from removal of one area of lung. Such a patient may need pulmonary rehabilitation, inhaled treatment where indicated, vaccination, nutritional support, airway-clearance strategies, and specialist respiratory care. In contrast, a patient with otherwise good lungs but one severely bronchiectatic lobe causing repeated pneumonia may potentially benefit from resection of that localised disease.
The central principle is therefore localisation. Surgery works best when the dangerous or symptomatic disease is anatomically identifiable and removable, while the remaining lung has enough reserve to support the patient comfortably.
Does Every Patient With Lung Damage After TB Need Surgery?
No. In fact, the majority of patients with radiological evidence of previous TB do not need thoracic surgery.
A CT scan may show scars, calcification, minor cavities, or limited bronchiectatic changes in someone who feels well and has no repeated infections or bleeding. Operating simply because a scan looks abnormal is rarely sensible. Surgery has a clear role when the expected benefit of removing the diseased area is greater than the risk of the operation and the loss of functioning lung tissue.
Before considering surgery, we usually ask several practical questions. Is the patient having recurrent or significant haemoptysis? Are infections occurring repeatedly despite appropriate medical treatment? Is there an aspergilloma inside an old cavity? Is the abnormality confined to one lobe or one lung? Is the affected lung contributing useful respiratory function, or has it become a non-functioning source of sepsis? Can the patient tolerate the proposed operation?
These questions matter because post-TB lung surgery is not a cosmetic repair of an abnormal scan. Its purpose is to solve a meaningful clinical problem. The operation may prevent life-threatening bleeding, remove a chronically infected lobe, eliminate a resectable fungal cavity, or deal with a severely destroyed and repeatedly infected lung.
The timing of surgery is equally important. Operating during uncontrolled infection, severe malnutrition, or uncertain TB activity may increase risk. Careful preparation—including microbiological assessment, bronchoscopy in selected patients, nutritional optimisation, pulmonary function testing, and precise anatomical mapping—is often as important as the operation itself.
The Main Reasons When Surgery May Be Needed After TB
There are several recognised situations in which a thoracic surgical opinion becomes particularly important. These conditions often overlap. A patient may simultaneously have bronchiectasis, an old cavity, fungal colonisation, and recurrent bleeding.
Recurrent or Massive Coughing of Blood
Haemoptysis, or coughing up blood, is one of the most frightening late complications seen after pulmonary tuberculosis. The amount may range from streaks in the sputum to sudden major bleeding (massive hemoptysis) that threatens the airway and life.
The source of bleeding is not always active tuberculosis. Old TB can distort the lung and its blood vessels. Bronchiectatic airways become inflamed and vascular. Chronic cavities can erode adjacent vessels. Aspergilloma may develop in a residual cavity. Occasionally, a pulmonary artery pseudoaneurysm, traditionally referred to as a Rasmussen aneurysm in the appropriate setting, may be responsible.
The first priority in significant haemoptysis is stabilisation and identification of the source. Contrast-enhanced CT angiography and bronchoscopy may be needed depending on the clinical situation. Bronchial artery embolisation can be extremely valuable for controlling acute bleeding, particularly as an emergency measure or when the patient is not immediately fit for surgery.
However, embolisation and surgery serve different purposes. Embolisation blocks the bleeding vessel; surgery removes the structural disease responsible for the bleeding. If a patient repeatedly bleeds from a clearly localised destroyed lobe, bronchiectatic segment, or aspergilloma, definitive surgical resection may be considered after detailed assessment.
The key message for patients is simple: recurrent haemoptysis after TB should never be dismissed as “old TB.” It requires investigation to identify the actual cause.
Aspergilloma or Fungal Ball in an Old TB Cavity
Tuberculosis can leave behind cavities, and these empty spaces can later be colonised by the fungus Aspergillus. Over time, a mass composed of fungal elements, mucus, fibrin, and cellular debris may form inside the cavity. This is commonly called an aspergilloma or fungal ball.
The classic presentation of Aspergilloma after TB is haemoptysis. Some patients experience occasional blood-streaked sputum, while others develop repeated or potentially life-threatening bleeding. The clinical spectrum of chronic pulmonary aspergillosis is broader than a simple fungal ball, so diagnosis and treatment need to distinguish a relatively localised aspergilloma from more extensive chronic cavitary disease.
For a symptomatic, localised simple aspergilloma in a patient with adequate pulmonary reserve, surgical resection can provide definitive treatment. Depending on the location and extent of disease, the procedure may involve wedge resection, segmentectomy, or lobectomy. Complex aspergilloma surrounded by dense fibrosis, destroyed lung tissue, and severe pleural adhesions requires much more careful risk assessment.
This is one area where early specialist review can be useful. Waiting until a patient has repeated major bleeding, severe anaemia, worsening infection, and poor nutritional status may make an already challenging operation more difficult.
Localised Bronchiectasis With Recurrent Infections
Bronchiectasis is a common structural consequence of previous pulmonary TB. The bronchi become permanently dilated and lose their ability to clear secretions effectively. Mucus collects, bacteria multiply, inflammation increases, and further airway damage follows. It becomes a vicious cycle.
Many patients with bronchiectasis after TB can be treated without surgery. Airway clearance, sputum-guided antibiotics, treatment of associated conditions, vaccination, exercise, and pulmonary rehabilitation form important parts of management. Surgery enters the discussion when disease is severely symptomatic, anatomically localised, and persistent despite appropriate medical treatment.
Consider a patient with a badly damaged upper lobe who develops four or five significant infections every year, repeatedly needs antibiotics or hospital admission, produces large volumes of purulent sputum every morning, and occasionally coughs blood. If the remaining lungs are reasonably healthy and the disease is clearly localised, removing the damaged lobe may break the cycle.
By contrast, diffuse bronchiectasis involving multiple lobes in both lungs is generally not solved by removing one part of the lung. The CT pattern and the relationship between symptoms and the localised abnormality are therefore crucial.
Destroyed Lung After Tuberculosis
A destroyed lung is one of the most severe consequences of pulmonary TB. The affected lung may become extensively fibrotic, contracted, cavitated, bronchiectatic, and chronically infected. There may be significant mediastinal shift, compensatory over-expansion of the opposite lung, recurrent infection, persistent sputum production, and haemoptysis.
Not every radiologically destroyed lung needs removal. If the patient is stable, symptoms are limited, and there is no major recurrent infection or bleeding, observation and medical management may be appropriate.
Surgery becomes a consideration when the destroyed lung is causing repeated severe infection, uncontrolled or recurrent haemoptysis, persistent sepsis, significant suppuration, or other major complications. In such situations, pneumonectomy—removal of the entire lung—may occasionally be required.
This is a major operation and should not be taken lightly. Previous TB can create dense adhesions, calcified lymph nodes, distorted hilar anatomy, and enlarged bronchial arteries. These factors can increase technical complexity and bleeding risk. The decision should therefore be made after detailed physiological assessment and careful evaluation by a team experienced in complex thoracic surgery.
Chronic Empyema and Trapped Lung
Tuberculosis can affect not only the lung but also the pleural space surrounding it. Chronic infection may result in empyema, where infected material or pus accumulates in the pleural cavity. Over time, the lung may become encased in a thick fibrous layer and lose the ability to expand normally.
The operation required depends on the stage and anatomy of the disease. Some patients may require drainage and medical therapy. Others may need decortication, an operation in which the restrictive fibrous peel is removed to allow the underlying lung to expand. In complex chronic disease, additional procedures may be required depending on whether the lung remains expandable, whether a bronchopleural fistula is present, and whether there is extensive parenchymal destruction.
The objective is not merely to remove fluid from the chest. It is to control infection, close abnormal communications where necessary, and restore useful lung expansion when realistically possible.
Chronic post-TB pleural disease is highly individual. A CT scan, microbiology, assessment of the underlying lung, and sometimes bronchoscopy are required before choosing the operation.
Persistent Cavities and Selected Drug-Resistant TB Cases
Modern anti-tubercular treatment remains the foundation of TB care. Surgery does not replace appropriate antimicrobial therapy.
However, thoracic surgery may have an adjunctive role in carefully selected patients with localised disease and difficult microbiological circumstances, particularly when drug resistance, persistent cavitary disease, or failure of medical therapy creates a highly specialised problem. Historical and contemporary surgical literature describes resection as an option in selected patients with persistent positive cultures, relapse, or localised disease in the setting of drug resistance.
These decisions require multidisciplinary planning with specialists experienced in drug-resistant TB. The timing of surgery, duration of effective drug therapy before and after the operation, extent of resection, sputum status, and drug-susceptibility profile all matter.
The important distinction is that surgery is an adjunct, not an alternative to an effective TB regimen. A patient with suspected persistent active disease should not simply be sent for lung resection without complete microbiological and multidisciplinary assessment.
How Doctors Decide Whether Surgery Is Safe
The question “Can this abnormal lung be removed?” is only half the assessment. The equally important question is “What will the patient’s respiratory function be after it is removed?”
Post-TB patients can be deceptive. A severely damaged lobe may look large on CT but contribute little useful ventilation. In another patient, apparently limited resection may have a greater physiological impact because the remaining lung is also diseased. This is why decisions cannot be made from a single image.
A comprehensive assessment may include high-resolution CT or contrast-enhanced CT, pulmonary function tests, sputum studies, bronchoscopy, blood tests, nutritional assessment, cardiac evaluation, and additional functional testing when needed.
The surgical plan should be tailored to the disease. The smallest appropriate resection is preferred when it adequately removes the problem, but inadequate resection of extensive diseased tissue can leave the patient with persistent symptoms.
CT Scan and Identifying the Diseased Lung
A good-quality CT scan is the roadmap for post-TB surgery. It shows whether the disease is confined to a segment, a lobe, several lobes, or an entire lung. It can reveal cavities, bronchiectasis, fibrosis, aspergilloma, pleural thickening, calcified lymph nodes, compensatory changes in the opposite lung, and other abnormalities relevant to surgical planning.
In patients with haemoptysis, CT angiographic evaluation may help identify abnormal systemic vessels and guide embolisation or operative strategy. A bronchoscopy may be required to exclude an endobronchial lesion, assess airway anatomy, collect samples, or help localise the side of bleeding.
One common mistake is to treat every shadow in a previously treated TB patient as recurrent TB. Persistent symptoms may arise from bronchiectasis, fungal disease, bacterial infection, airway stenosis, malignancy, or another condition altogether.
The diagnosis must therefore come before the operation.
Lung Function and Fitness Assessment
Pulmonary function testing helps estimate how much respiratory reserve a patient has and whether the planned resection is physiologically reasonable. FEV1 and DLCO are important components of evaluation, although additional tests may be necessary for major resections.
For selected patients, exercise assessment, arterial blood gas analysis, echocardiography, perfusion assessment, or cardiopulmonary exercise testing may provide additional information. The exact tests depend on the proposed operation and the patient’s overall health.
Nutrition also deserves attention. Patients with chronic suppuration or fungal disease may be underweight, anaemic, or nutritionally depleted. Improving nutrition, treating active bacterial infection, optimising airway clearance, stopping smoking, and improving physical conditioning before surgery can influence recovery.
Good surgery begins before the patient reaches the operating room.
What Operations Are Performed for Post-TB Lung Damage?
There is no single operation called “TB surgery.” The procedure depends on where the disease is located and how extensive it is.
A small peripheral localised lesion may require limited resection. Disease confined to one anatomical segment may occasionally be treated by segmentectomy. A destroyed or severely bronchiectatic lobe may require lobectomy. Extensive destruction of an entire lung may require pneumonectomy in highly selected patients.
Pleural disease follows a different surgical pathway. Patients with organised empyema and an expandable underlying lung may benefit from decortication, while more complex situations involving chronic cavities or bronchopleural fistulae require individualised strategies.
The aim is always the same: remove or correct the disease responsible for the patient’s major symptoms while preserving as much useful lung function as possible.
Segmentectomy and Lobectomy
A segmentectomy removes an anatomical segment of the lung, while a lobectomy removes an entire lobe. The choice depends on the distribution of disease rather than a preference for one operation over another.
Post-TB disease often does not respect neat surgical boundaries. Fibrosis and infection may cross segments, and dense hilar scarring can make anatomical dissection challenging. For this reason, the operation must be planned from detailed imaging.
When disease is genuinely confined to one segment and complete removal is technically feasible, lung-preserving resection may be considered. When a whole lobe is bronchiectatic, destroyed, or contains the symptomatic cavity, lobectomy may be the more appropriate operation.
Preserving lung is valuable, but leaving behind severely diseased tissue simply to perform a smaller operation can defeat the purpose of surgery.
Pneumonectomy for a Completely Destroyed Lung
Pneumonectomy means removal of an entire lung. In post-TB disease, it is generally reserved for severe unilateral destruction when the affected lung has become a persistent source of major symptoms or complications and the opposite lung can support the patient.
This operation requires particularly careful selection. Post-TB pneumonectomy can be more complex than pneumonectomy for some other conditions because chronic inflammation may obliterate normal tissue planes. Dense adhesions and abnormal systemic vascularity can increase operative difficulty.
There are also important postoperative risks, including respiratory complications and bronchopleural fistula. For this reason, the indication should be strong and the assessment detailed.
Yet for the right patient—a person with one non-functioning, chronically infected, repeatedly bleeding destroyed lung and a healthy contralateral lung—surgery can address a problem that repeated courses of medication cannot structurally correct.
VATS and Minimally Invasive Surgery After TB
Can surgery after tuberculosis be performed using VATS, or video-assisted thoracic surgery?
In selected cases, yes.
Modern minimally invasive thoracic surgery allows many lung and pleural operations to be performed through small incisions without the traditional large thoracotomy. Potential advantages can include less postoperative pain, earlier mobilisation, and faster functional recovery.
However, previous TB can make minimally invasive surgery technically demanding. Dense pleural adhesions, calcified lymph nodes around pulmonary vessels, fused tissue planes, and abnormal vascularity can all increase complexity. Therefore, the surgical approach should be chosen according to anatomy and safety rather than ideology.
A straightforward localised lesion with favourable anatomy may be suitable for VATS. A severely destroyed lung with extensive hilar fibrosis may require a different approach. Conversion from minimally invasive surgery to open surgery, when necessary for safety, should be viewed as sound surgical judgment rather than failure.
The right operation is the one that solves the patient’s problem safely.
Recovery and Results After Surgery
Recovery after surgery for post-TB lung disease depends on the type of operation and the patient’s condition before surgery.
A patient undergoing minimally invasive lobectomy for localised disease will usually have a very different recovery from someone undergoing pneumonectomy for a severely destroyed lung. Age, nutrition, smoking history, baseline lung function, infection status, and the condition of the remaining lung all influence the postoperative course.
Early recovery focuses on pain control, breathing exercises, mobilisation, chest physiotherapy, airway clearance, and prevention of infection and blood clots. Patients with long-standing sputum production often need particularly careful respiratory physiotherapy.
The expected benefit also varies according to the indication. After resection of localised bronchiectasis, the goal may be fewer infections and less sputum. After surgery for a symptomatic aspergilloma, the aim may be prevention of recurrent bleeding and removal of the fungal cavity. After surgery for destroyed lung, the objective may be control of recurrent sepsis or haemoptysis.
Patient selection is the foundation of good outcomes. A technically successful operation cannot compensate for a poorly chosen indication. Equally, repeatedly treating a surgically correctable structural problem with temporary medication may expose a suitable patient to years of preventable illness.
Conclusion
So, when is surgery needed after TB?
Surgery is considered when tuberculosis has left behind a structural problem that is causing significant symptoms or dangerous complications and cannot be adequately controlled by medical treatment alone. The common situations include recurrent or major haemoptysis, symptomatic aspergilloma, localised bronchiectasis with repeated infections, chronic empyema with trapped lung, and selected cases of severely destroyed lung. Surgery may also have an adjunctive role in carefully selected cases of localised difficult-to-treat or drug-resistant TB under multidisciplinary care.
The presence of a scar, cavity, or damaged area on CT does not automatically mean that an operation is necessary. The decision depends on symptoms, disease localisation, microbiology, lung function, the health of the remaining lung, and the technical feasibility of safe resection.
The most useful principle for patients to remember is this: TB treatment may kill the bacteria, but it cannot always reverse structural lung damage that has already occurred. If a person continues to have recurrent chest infections, daily purulent sputum, worsening breathlessness, or coughing of blood after TB treatment, the cause should be investigated rather than automatically attributed to an old scar.
In selected patients, thoracic surgery can address the damaged part of the lung that has become the source of the problem. The decision, however, should be individualised and made after detailed assessment by a team experienced in complex lung and post-infectious thoracic disease.
Frequently Asked Questions
1. Can a person need lung surgery years after completing TB treatment?
Yes. Some complications of previous tuberculosis become symptomatic months or years after treatment has finished. Old cavities may develop aspergilloma, damaged bronchi may cause recurrent infections, and post-TB bronchiectasis can lead to repeated haemoptysis. The correct treatment depends on the current structural problem, not simply on how long ago the TB occurred.
2. Is coughing blood after TB always a sign that TB has returned?
No. Recurrent TB is one possibility, but haemoptysis may also arise from bronchiectasis, an aspergilloma, chronic cavitary disease, abnormal bronchial arteries, or vascular complications. Significant or recurrent haemoptysis needs proper investigation rather than assumptions based on previous TB history.
3. Can a fungal ball after TB be treated without surgery?
Treatment depends on whether the patient has a simple localised aspergilloma or a broader form of chronic pulmonary aspergillosis, as well as symptoms, bleeding history, lung reserve, and surgical risk. A symptomatic, localised simple aspergilloma in a suitable surgical candidate may be treated by resection, while other forms of chronic pulmonary aspergillosis often require antifungal therapy and specialist management.
4. Can surgery for post-TB lung damage be done by VATS?
Yes, selected patients can undergo VATS surgery. Suitability depends on the extent of fibrosis, pleural adhesions, calcified lymph nodes, abnormal vascularity, and the operation required. Safety and complete treatment of the disease are more important than using a particular surgical approach.
5. Can someone live normally after removal of a lobe damaged by TB?
Many carefully selected patients can return to active lives after lobectomy, particularly when the removed lobe was already badly damaged and contributing little useful function. Recovery depends on the health of the remaining lungs, preoperative lung function, fitness, nutrition, and associated medical conditions. Proper preoperative assessment is therefore essential before recommending surgery.
Here is a publication-ready SEO package for the article, followed by a curated reference list. I would keep the title focused on the primary search intent while using “post-TB lung damage” and specific complications as secondary keywords.
References and Recommended Links
These references are appropriate for the evidence base of the article and include a mix of current guidelines, recent reviews, and authoritative clinical literature:
- World Health Organization. Global Tuberculosis Report 2025. The latest WHO global assessment of TB epidemiology, diagnosis, treatment, and outcomes. (World Health Organization)
WHO Global Tuberculosis Report 2025 - Al-Hindawi Y, et al. Post-tuberculosis lung disease. Breathe, 2026. A current review covering PTLD manifestations including bronchiectasis, airflow limitation, structural lung damage, and post-treatment assessment. (ERS Publications)
Post-tuberculosis lung disease – European Respiratory Society - Chalmers JD, et al. European Respiratory Society Clinical Practice Guideline for the Management of Adult Bronchiectasis. European Respiratory Journal, 2025. The current ERS framework for assessment and treatment of adult bronchiectasis. (ERS Publications)
ERS Clinical Practice Guideline for Adult Bronchiectasis - Denning DW, et al. Chronic Pulmonary Aspergillosis: Rationale and Clinical Guidelines for Diagnosis and Management. European Respiratory Journal. This guideline is particularly relevant to the sections discussing post-TB cavities, aspergilloma, haemoptysis, and surgical selection; it recommends surgical excision for technically resectable simple aspergilloma. (PubMed)
Chronic Pulmonary Aspergillosis Clinical Guideline - Patterson TF, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases. A major professional-society guideline covering chronic and saprophytic forms of pulmonary aspergillosis alongside invasive disease. (Infectious Diseases Society of America)
IDSA Aspergillosis Guideline - Subotic D, et al. Surgery and Pleuro-Pulmonary Tuberculosis: A Scientific Literature Review. Journal of Thoracic Disease, 2016. A focused review of the role of thoracic surgery in complex pulmonary and pleural TB, including surgical indications and the role of surgery in difficult cases. (PMC)
Surgery and Pleuro-Pulmonary Tuberculosis Review - Sihoe ADL. Role of Surgery in the Diagnosis and Management of Tuberculosis. A useful thoracic surgical review discussing how modern surgery can contribute to the management of selected TB cases and complications. (PMC)
Role of Surgery in Tuberculosis Management - Salami MA, et al. Current Indications and Outcome of Pulmonary Resections for Tuberculosis Complications. Relevant to the sections on lung resection for post-TB complications and drug-resistant disease. (PMC)
Pulmonary Resections for Tuberculosis Complications - World Health Organization. WHO Consolidated Guidelines on Tuberculosis: Module 4 – Treatment and Care, 2025. An important reference for current treatment of drug-susceptible and drug-resistant TB and the principle that surgery, where considered, complements rather than replaces appropriate antimicrobial therapy. (World Health Organization)
WHO Consolidated TB Guidelines: Treatment and Care
Related Articles:
- Post Tuberculosis Lung Damage: Understanding Life After TB
- Destroyed Lung After TB
- Massive Hemoptysis After TB
- Bronchiectasis After TB
- Aspergilloma After TB
- Post-TB Fibrosis
- Surgery for Destroyed Lung
- Living With One Destroyed Lung
Author
Dr. Kamran Ali
Associate Director – Thoracic Surgery
Max Super Speciality Hospital, Saket, New Delhi
Dr. Kamran Ali specializes in minimally invasive thoracic surgery (VATS and Robotic Surgery), lung cancer surgery, surgery for post-tuberculous lung diseases, bronchiectasis, aspergilloma, empyema, airway surgery, and lung transplantation. He offers advanced bronchoscopic evaluation, multidisciplinary treatment planning, and definitive surgical management when required.
Medical Disclaimer:
This article is intended for educational purposes only and should not replace professional medical advice. Early diagnosis and treatment by an experienced pulmonologist and thoracic surgeon can be life-saving
